Figures & data
Figure 1 Characterization of Al2O3NPs.
Notes: (A) TEM image; (B) size distribution (percentage, %) of Al2O3NPs, as generated by TEM imaging.
Abbreviations: Al2O3NPs, alumina nanoparticles; TEM, transmission electron microscopy.
![Figure 1 Characterization of Al2O3NPs.Notes: (A) TEM image; (B) size distribution (percentage, %) of Al2O3NPs, as generated by TEM imaging.Abbreviations: Al2O3NPs, alumina nanoparticles; TEM, transmission electron microscopy.](/cms/asset/7ef6ada3-93ca-4ff8-8fd7-0d5a814aca62/dijn_a_82050_f0001_c.jpg)
Figure 2 Morphology of HepG2 cells.
Notes: (A) Control HepG2 cells. HepG2 cells were treated with 450 μg/mL of Al2O3NPs for (B) 24 hours and (C) 48 hours. Scale bar: 100 μm.
Abbreviations: Al2O3NPs, alumina nanoparticles; HepG2, human hepatocarcinoma cells.
![Figure 2 Morphology of HepG2 cells.Notes: (A) Control HepG2 cells. HepG2 cells were treated with 450 μg/mL of Al2O3NPs for (B) 24 hours and (C) 48 hours. Scale bar: 100 μm.Abbreviations: Al2O3NPs, alumina nanoparticles; HepG2, human hepatocarcinoma cells.](/cms/asset/af7518ea-3bba-4cbe-8885-469279801fcc/dijn_a_82050_f0002_b.jpg)
Figure 3 Cytotoxicity of Al2O3NPs toward HepG2 cells after treatment for 24 hours and 48 hours, as measured by the (A) MTT and (B) NRU tests.
Notes: Each value represents the mean ± SEM of three experiments. *P<0.05 vs control.
Abbreviations: Al2O3NPs, alumina nanoparticles; HepG2, human hepatocarcinoma cells; NRU, neutral red uptake; SEM, standard error of the mean.
![Figure 3 Cytotoxicity of Al2O3NPs toward HepG2 cells after treatment for 24 hours and 48 hours, as measured by the (A) MTT and (B) NRU tests.Notes: Each value represents the mean ± SEM of three experiments. *P<0.05 vs control.Abbreviations: Al2O3NPs, alumina nanoparticles; HepG2, human hepatocarcinoma cells; NRU, neutral red uptake; SEM, standard error of the mean.](/cms/asset/e52810d4-caa7-4c01-83e0-1b0151782043/dijn_a_82050_f0003_b.jpg)
Figure 4 Al2O3NP-induced ROS levels in HepG2 cells.
Notes: (A) Control cells. HepG2 cells incubated with (B) 150 μg/mL and (C) 450 μg/mL of Al2O3NPs for 48 hours. (D) Percentage ROS production at various doses of Al2O3NPs in HepG2 cells. Each value represents the mean ± SEM of three experiments. *P<0.05 vs control. Scale bar: 50 μm.
Abbreviations: Al2O3NPs, alumina nanoparticles; DCF, 2,7-dichlorofluorescein; HepG2, human hepatocarcinoma cells; ROS, reactive oxygen species; SEM, standard error of the mean.
![Figure 4 Al2O3NP-induced ROS levels in HepG2 cells.Notes: (A) Control cells. HepG2 cells incubated with (B) 150 μg/mL and (C) 450 μg/mL of Al2O3NPs for 48 hours. (D) Percentage ROS production at various doses of Al2O3NPs in HepG2 cells. Each value represents the mean ± SEM of three experiments. *P<0.05 vs control. Scale bar: 50 μm.Abbreviations: Al2O3NPs, alumina nanoparticles; DCF, 2,7-dichlorofluorescein; HepG2, human hepatocarcinoma cells; ROS, reactive oxygen species; SEM, standard error of the mean.](/cms/asset/052b2820-2b18-4579-be5f-66df886749a5/dijn_a_82050_f0004_c.jpg)
Figure 5 Al2O3NP-induced oxidative stress.
Notes: Levels of (A) LPO, (B) GSH, and (C) SOD in HepG2 cells after treatment with Al2O3NPs for 24 hours and 48 hours. Each value represents the mean ± SEM of three experiments. *P<0.05 vs control.
Abbreviations: Al2O3NPs, alumina nanoparticles; GSH, reduced glutathione; HepG2, human hepatocarcinoma cells; LPO, lipid peroxidation; MDA, malondialdehyde; SEM, standard error of the mean; SOD, superoxide dismutase.
![Figure 5 Al2O3NP-induced oxidative stress.Notes: Levels of (A) LPO, (B) GSH, and (C) SOD in HepG2 cells after treatment with Al2O3NPs for 24 hours and 48 hours. Each value represents the mean ± SEM of three experiments. *P<0.05 vs control.Abbreviations: Al2O3NPs, alumina nanoparticles; GSH, reduced glutathione; HepG2, human hepatocarcinoma cells; LPO, lipid peroxidation; MDA, malondialdehyde; SEM, standard error of the mean; SOD, superoxide dismutase.](/cms/asset/655b7ecb-85e3-4b32-a361-6e9f5e26af9e/dijn_a_82050_f0005_b.jpg)
Figure 6 Chromosomal condensation and induction of caspase-3 activity in HepG2 cells after treatment with Al2O3NPs.
Notes: (A) Control. Cells treated with 150 μg/mL of Al2O3NPs for (B) 24 hours and (C) 48 hours. (D) Caspase-3 activity. Each value represents the mean ± SEM of three experiments. *P<0.05 vs control. Scale bar: 50 μm.
Abbreviations: Al2O3NPs, alumina nanoparticles; HepG2, human hepatocarcinoma cells; SEM, standard error of the mean.
![Figure 6 Chromosomal condensation and induction of caspase-3 activity in HepG2 cells after treatment with Al2O3NPs.Notes: (A) Control. Cells treated with 150 μg/mL of Al2O3NPs for (B) 24 hours and (C) 48 hours. (D) Caspase-3 activity. Each value represents the mean ± SEM of three experiments. *P<0.05 vs control. Scale bar: 50 μm.Abbreviations: Al2O3NPs, alumina nanoparticles; HepG2, human hepatocarcinoma cells; SEM, standard error of the mean.](/cms/asset/effb498d-cf37-4d32-823a-2fb3c0ec3836/dijn_a_82050_f0006_c.jpg)
Figure 7 DNA lesions in HepG2 cells due to Al2O3NPs.
Notes: (A) Tail DNA (percentage). (B) Control cells. (C) HepG2 cells treated with 150 μg/mL of Al2O3NPs for 48 hours. Each value represents the mean ± SEM of three experiments. *P<0.05 vs control. Scale bar: 20 μm.
Abbreviations: Al2O3NPs, alumina nanoparticles; HepG2, human hepatocarcinoma cells; SEM, standard error of the mean.
![Figure 7 DNA lesions in HepG2 cells due to Al2O3NPs.Notes: (A) Tail DNA (percentage). (B) Control cells. (C) HepG2 cells treated with 150 μg/mL of Al2O3NPs for 48 hours. Each value represents the mean ± SEM of three experiments. *P<0.05 vs control. Scale bar: 20 μm.Abbreviations: Al2O3NPs, alumina nanoparticles; HepG2, human hepatocarcinoma cells; SEM, standard error of the mean.](/cms/asset/602eeb46-5026-49dd-9212-a1d32259e1b4/dijn_a_82050_f0007_c.jpg)